News >

CD200, CD56 Expression Predict Poor Prognosis in Pediatric B-ALL

Jason Harris
Published: Wednesday, Nov 29, 2017

multiple myeloma
Children with B-cell acute lymphoblastic leukemia (B-ALL) who were positive for CD200 and/or CD56 expression had significantly poorer overall survival (OS) and disease-free survival (DFS), according to findings from a small study.

Investigators noted that CD200 expression was not significantly associated with age, sex, male gender, splenomegaly, or lower hemoglobin, but was significantly associated with lower platelet count.
Aref S, Azmy E, El-bakry K, et al. Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients [published online November 16, 2017. Pediatr Hematol Oncol. doi: 10.1080/08880018.2017.1363836.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication